NeuropsychopharmacologyJClub
Evidence for pro-cognitive benefits of cannabinoids in people with bipolar disorder.
Neuropsychopharmacology · · Randomized Controlled Trial · Open access
Miranda, Holloway + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Chronic cannabis use in people with bipolar disorder is linked to temporal discrimination and attention/inhibitory control performance that is comparable to non–cannabis-using healthy comparison adults.
- Why it matters: Bipolar disorder is associated with impaired temporal perception and attention/inhibitory control deficits, and acute cannabis exposure slows timing, but the real-world cognitive and timing effects of cannabis use in bipolar disorder are unclear.
- What they did: Two studies tested bipolar disorder and healthy comparison adults using the Temporal Discrimination Task and 5-Choice Continuous Performance Task, including a randomized clinical trial of acute THC versus placebo in non–cannabis-using participants.
- The result: In the chronic study, non–cannabis-using bipolar disorder participants showed less precise timing than other groups, while bipolar disorder with cannabis use showed comparable TDT and 5C-CPT performance to non–cannabis-using healthy comparison adults; in the acute trial, THC produced faster timing in bipolar disorder versus placebo-treated healthy comparison participants.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.